Welcome to our Milestones in Public Health podcasts page. We invite you to listen in as Barbara A. DeBuono, MD, MPH, Senior Medical Advisor, Pfizer Public Health and Policy Group and a nationally recognized public health expert and reviewer from the book pick up where they left off by discussing new issues, challenges and advancements within their subject area.
Subscribe to the Milestones in Public Health Podcasts RSS feed!
Milestones Topic: Infectious Disease ControlDr. DeBuono discusses Infectious Disease Control with James Curran, MD, MPH, Rollins School of Public Health, Emory University.
Download the podcast (MP3, 9.76 MB)
Posted on: December 8th, 2006
Download the podcast (MP3, 8.22 MB)Posted on: November 27th, 2006
Milestones Topic: Addiction
Dr. DeBuono discusses Addiction with Joseph Califano, Jr., National Center on Addiction and Substance Abuse, Columbia University.
Download the podcast (MP3, 9.65 MB)
Posted on: November 10th, 2006
Milestones Topic: Oral Health
Dr. DeBuono discusses Oral Health with Myron Allukian, DDS, MPH, Former Director of Oral Health, Boston Public Health Commission.
Download the podcast (MP3, 10.67 MB)
Posted on: October 27th, 2006
Milestones Topic: Cardiovascular Disease
Dr. DeBuono discusses Cardiovascular Disease with Thomas Pearson, MD, MPH, PhD, University of Rochester School of Medicine.
Download the podcast (MP3, 11.77 MB)
Posted on: October 13th, 2006
Milestones Topic: Public Health Infrastructure
Dr. DeBuono discusses Public Health Infrastructure with expert reviewer C. William Keck, MD, MPH, Northeastern Ohio Universities College of Medicine.
Download the podcast (MP3, 9.88 MB)
Posted on: September 29, 2006
Milestones Topic: Safer and Healthier Foods
Dr. DeBuono discusses Safer and Healthier Foods with expert reviewer Ernest Julian, PhD, Rhode Island Department of Health.
Download the podcast (MP3, 7.86 MB)
Posted on: September 15, 2006
LEGAL DISCLAIMER:The opinions expressed in materials contained on this website are the opinions of the individual author and may not reflect the opinions of Pfizer Inc., or any of its partners or employees.